Profile data is unavailable for this security.
About the company
Frontier Biotechnologies Inc is a China-based company engaged in research and development, production and sales of innovative drugs. The Company's products include Aikening and Combination regiment of Albuvirtide (ABT) + 3BNC117 which is during clinical stage for treatment of human immunodeficiency virus (HIV). Its clinical-stage products also include transdermal analgesic patch AB001 for treating muscle, skeleton and joint pain. The Company conducts its businesses within the China market and to overseas markets.
- Revenue in CNY (TTM)122.86m
- Net income in CNY-316.34m
- Incorporated2013
- Employees395.00
- LocationFrontier Biotechnologies IncHi-Tech Park, Jiangning DistrictNANJING 211199ChinaCHN
- Phone+86 2 569648375
- Fax+86 2 569748373
- Websitehttp://www.frontierbiotech.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hanshang Group Co Ltd | 1.31bn | 21.51m | 2.21bn | 2.38k | 98.97 | 1.29 | -- | 1.68 | 0.0757 | 0.0757 | 4.46 | 5.83 | 0.3718 | 2.65 | 8.25 | 552,235.40 | 0.3729 | 2.00 | 0.6192 | 3.89 | 55.85 | 57.24 | 1.00 | 4.89 | 0.2774 | 1.84 | 0.3798 | 15.03 | 0.1893 | 5.14 | -32.24 | 25.62 | 12.88 | -- |
Frontier Biotechnologies Inc | 122.86m | -316.34m | 2.31bn | 395.00 | -- | 1.96 | -- | 18.84 | -0.8445 | -0.8445 | 0.328 | 3.16 | 0.057 | 1.43 | 2.91 | 311,049.00 | -14.67 | -14.05 | -17.86 | -15.78 | 31.82 | 2.35 | -257.47 | -450.08 | 2.11 | -- | 0.2763 | -- | 34.82 | 126.63 | 7.79 | -- | 28.13 | -- |
Ginwa Enterprise Group Inc | 556.00m | -36.47m | 2.42bn | 553.00 | -- | 1.52 | -- | 4.34 | -0.0977 | -0.0977 | 1.49 | 4.25 | 0.2984 | 4.83 | 5.59 | 1,005,424.00 | -1.96 | 0.3641 | -2.25 | 0.4141 | 75.45 | 73.64 | -6.56 | 1.15 | 2.66 | -0.078 | 0.0698 | 124.25 | -2.41 | -5.37 | -228.19 | -- | 61.66 | -- |
Zhejiang Cheng Yi Pharmaceutical Co Ltd | 706.56m | 148.76m | 2.49bn | 738.00 | 16.82 | 2.07 | -- | 3.53 | 0.4529 | 0.4529 | 2.15 | 3.68 | 0.3938 | 2.11 | 11.86 | 957,393.10 | 8.26 | 12.01 | 10.55 | 14.75 | 65.42 | 69.79 | 20.98 | 22.84 | 0.7041 | -- | 0.2416 | 36.44 | 2.54 | 4.24 | 0.8129 | 10.94 | -23.56 | 12.84 |
Data as of Oct 11 2024. Currency figures normalised to Frontier Biotechnologies Inc's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Nuode Asset Management Co., Ltd.as of 21 Mar 2023 | 4.81m | 2.34% |
UBS Asset Management Switzerland AGas of 21 Mar 2023 | 4.63m | 2.25% |
Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.16m | 0.57% |
AEON Insurance Asset Management Co., Ltd.as of 21 Mar 2023 | 740.19k | 0.36% |
Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 719.31k | 0.35% |
SWS MU Fund Management Co., Ltd.as of 31 Dec 2023 | 719.22k | 0.35% |
Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 383.19k | 0.19% |
E Fund Management Co., Ltd.as of 31 Dec 2023 | 228.11k | 0.11% |
China Europe Fund Management Co., Ltd.as of 31 Dec 2023 | 120.81k | 0.06% |
Baoying Fund Management Co., Ltd.as of 31 Dec 2023 | 118.80k | 0.06% |
More ▼
Data from 09 Jun 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.